Financhill
Back

UroGen Pharma Vs. Amicus Therapeutics Industry Stock Comparison

Sell
43

URGN
UroGen Pharma

Last Price:
11.36
Seasonality Move:
5.08%
Sell
31

FOLD
Amicus Therapeutics

Last Price:
9.37
Seasonality Move:
-1.15%
Sell
43
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy, Sell or Hold?

  • The current UroGen Pharma [URGN] share price is $11.47. The Score for URGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.36. The Score for FOLD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

  • The UroGen Pharma share price today is $11.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.

URGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 39.41 Sell
Chaikin Money Flow: 14788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 33.68 Sell
Chaikin Money Flow: -3229558 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

URGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.05 Sell
20-day SMA: 11.99 Sell
50-day SMA: 12.21 Sell
200-day SMA: 14.16 Sell
8-day EMA: 11.93 Sell
20-day EMA: 12.08 Sell
50-day EMA: 12.39 Sell
200-day EMA: 13.6 Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.87 Sell
20-day SMA: 9.79 Sell
50-day SMA: 10.5 Sell
200-day SMA: 10.72 Sell
8-day EMA: 9.85 Sell
20-day EMA: 9.99 Sell
50-day EMA: 10.35 Sell
200-day EMA: 10.86 Sell

UroGen Pharma Earnings Growth & URGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):